1. Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy

   • Yan Ji
   • Sherwin K. B. Sy

   Review Article 02 March 2024 Pages: 273 - 293

   

2. CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms

   • Yuanpei Wang
   • Jing Wen
   • Fang Ren

   Original Article 08 November 2023 Pages: 295 - 306

   

3. Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults

   • Yizhe Chen
   • David Wyatt
   • Gopal Krishna

   Original Article Open access 13 November 2023 Pages: 307 - 317

   

4. Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study

   • Hiroaki Takahashi
   • Yoko Saito
   • Kenzo Kudo

   Original Article 28 November 2023 Pages: 319 - 328

   

5. Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study

   • Carla Biesdorf
   • Xiaowen Guan
   • Akshanth R. Polepally

   Original Article 30 November 2023 Pages: 329 - 339

   

6. Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study

   • Nobuaki Matsubara
   • Shota Kusuhara
   • Toshio Shimizu

   Original Article Open access 13 December 2023 Pages: 341 - 352

   

7. Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients

   • K. Westerdijk
   • S. D. Krens
   • N. P. van Erp

   Original Article Open access 17 December 2023 Pages: 353 - 364

   

8. Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule

   • Shinji Kobuchi
   • Atsuko Morita
   • Yukako Ito

   Original Article 20 December 2023 Pages: 365 - 379

   

9. Andrographolide inhibits Burkitt’s lymphoma by binding JUN and CASP3 proteins

   • Junquan Zeng
   • Yongliang Zheng
   • Tingting Liu

   Original Article Open access 26 December 2023 Pages: 381 - 391

   

10. Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer

    • Marie Lambert
    • Mathieu Alonso
    • Etienne Chatelut

    Short Communication 03 October 2023 Pages: 393 - 395